NCM
NVNO

Nantahala Capital Management’s enVVeno Medical NVNO Stock Holding History

Nantahala Capital Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,990
Closed -$2.37M – 166
2025
Q2 		$2.37M Hold
16,990
– – 0.09% 120
2025
Q1 		$1.56M Sell
16,990
-65
-0.4% -$7.24K 0.06% 112
2024
Q4 		$1.8M Hold
17,055
– – 0.08% 111
2024
Q3 		$2.01M Buy
17,055
+3,402
+25% +$625K 0.1% 98
2024
Q2 		$2.51M Sell
13,653
-511
-4% -$89.2K 0.15% 85
2024
Q1 		$2.7M Sell
14,164
-6,017
-30% -$1.08M 0.15% 84
2023
Q4 		$3.63M Buy
+20,181
New +$3.21M 0.22% 77

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nantahala Capital Management's NVNO Position: Q3 2025 in Review

Nantahala Capital Management sold out of enVVeno Medical (NVNO) in Q3 2025, closing a stake of 16,990 shares — an estimated $2.37M sold.

Nantahala Capital Management first reported a position in NVNO in Q4 2023 and held it in 7 quarters. The position peaked at $3.63M in Q4 2023. 36 funds tracked by Wall St. Rank hold NVNO as of Q3 2025.

  • Nantahala Capital Management reported no remaining enVVeno Medical position as of Q3 2025 after selling out during the quarter.
  • Nantahala Capital Management sold 16,990 enVVeno Medical shares in Q3 2025, an estimated $2.37M.
  • Nantahala Capital Management first reported a position in enVVeno Medical in Q4 2023 and held it in 7 quarters.
  • Nantahala Capital Management's enVVeno Medical position peaked at $3.63M in Q4 2023.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2025.

Based on Nantahala Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.